je.st
news
Deutsche Bank Upgrades Johnson & Johnson to "Buy"
2013-01-06 01:29:08| Biotech - Topix.net
The firm currently has a $82.00 price target on the stock, up from their previous price target of $75.00. The analysts wrote, "For the past several years, JNJ has weathered through patent expirations, a general slowdown in utilization trends, and challenges with its OTC businesses.
Tags: buy
bank
johnson
deutsche
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||